1. Global Large Bore Vascular Closure Devices Market
The global Large Bore Vascular Closure Devices market is projected to reach a revenue of $830.36 million in 2025 with a CAGR of 8.15% from 2025 to 2030. This growth rate indicates a robust expansion in the market, driven by increasing demand for advanced medical devices that facilitate quicker and safer vascular closure procedures.
Large Bore Vascular Closure Devices are specialized medical tools designed to effectively and quickly stop bleeding from large-caliber arterial wounds, typically used in transcatheter procedures such as Transcatheter Aortic Valve Replacement (TAVR), Endovascular Aneurysm Repair (EVAR), and other cardiovascular interventions. These devices are crucial in reducing the time required for hemostasis, minimizing patient recovery time, and enhancing overall procedural safety.
Global Large Bore Vascular Closure Devices Revenue (M USD) in 2025
2. Driving Factors of Large Bore Vascular Closure Devices Market
Increasing Prevalence of Cardiovascular Diseases: The rising incidence of cardiovascular diseases globally necessitates more frequent use of interventional procedures, thereby increasing the demand for vascular closure devices. Conditions such as aortic valve stenosis and aneurysms require advanced medical interventions that rely on these devices.
Technological Advancements: Continuous advancements in medical technology have led to the development of more efficient and reliable vascular closure devices. Innovations in material science and device design have improved the safety and efficacy of these products, making them more attractive to healthcare providers.
Aging Population: The global aging population is more susceptible to cardiovascular diseases, leading to an increased need for medical interventions. This demographic trend is a significant driver for the market, as older individuals often require more frequent and complex medical procedures.
Government Support and Initiatives: Governments and healthcare organizations are increasingly supporting the adoption of advanced medical devices to improve patient outcomes and reduce healthcare costs. Regulatory approvals and funding for research and development in this field are also contributing to market growth.
3. Limiting Factors of Large Bore Vascular Closure Devices Market
High Costs: The advanced technology and specialized materials used in these devices result in high production and purchase costs. This can limit their adoption, especially in regions with limited healthcare budgets.
Regulatory Challenges: The medical device industry is highly regulated, and obtaining approvals for new products can be a lengthy and costly process. Stringent regulatory requirements can slow down the introduction of new and improved devices to the market.
Product Recalls and Failures: Instances of product recalls and failures can erode market confidence and lead to legal and financial repercussions for manufacturers. Ensuring consistent product quality and reliability is a critical challenge for the industry.
Competition from Alternative Technologies: The market faces competition from alternative methods of vascular closure, such as manual compression and other mechanical devices. The preference for these alternatives can limit the market share of Large Bore Vascular Closure Devices.
Training and Expertise Requirements: The effective use of these devices often requires specialized training and expertise, which can be a barrier to their widespread adoption. The need for skilled healthcare professionals to operate these devices can limit their use in regions with limited medical infrastructure.
4. Large Bore Vascular Closure Devices Market Segment
Product Types
The global Large Bore Vascular Closure Devices market is segmented into different product types based on the size of the devices, namely 10F-15F, 16F-18F, 19-25F, and others. Each of these product types has distinct market dynamics and growth trajectories.
Among these, the 10F-15F product type holds the largest market share, accounting for approximately 50.05% with a market revenue of $415.63 million in 2025. This segment is widely used in various medical procedures due to its versatility and effectiveness in handling a broad range of arterial sizes. The 10F-15F devices are particularly popular in applications such as Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Aneurysm Repair (EVAR), where precise and reliable closure is crucial.
On the other hand, the 16F-18F product type is the fastest-growing segment with a market size of $267.09 million in 2025. This growth rate is slightly higher than that of the 10F-15F segment. The 16F-18F devices are gaining popularity due to their suitability for more complex procedures that require larger access sheaths. As medical technology advances and the need for more sophisticated interventions increases, the demand for 16F-18F devices is expected to continue rising.
The 19-25F and Others segments also contribute significantly to the market. These segments cater to specialized applications and niche markets, driving their growth through targeted innovations and expanding clinical indications.
Market by Applications
The applications of Large Bore Vascular Closure Devices are diverse, encompassing critical cardiovascular procedures such as TAVR, EVAR, Ventricular Assist Device (VAD) implantation, and Balloon Aortic Valvuloplasty (BAV). Each application has distinct market dynamics and growth prospects.
Among these applications, TAVR holds the largest market share, accounting for approximately 39.61% of the total market revenue. TAVR is a minimally invasive procedure used to replace a narrowed aortic valve, and it has become increasingly popular due to its effectiveness in treating severe aortic valve stenosis, especially in high-risk patients. The growing prevalence of cardiovascular diseases and the aging population are key drivers for the increasing demand for TAVR procedures, thereby boosting the market for related vascular closure devices.
The EVAR application is the second-largest segment, with a market share of 30.20% in 2025. EVAR is used to repair abdominal aortic aneurysms, and its market growth is driven by advancements in endovascular techniques and the increasing number of patients requiring such interventions.
The VAD application, which involves the implantation of mechanical pumps to support heart function, is also a significant segment. The BAV application, is used for treating congenital aortic valve stenosis and other conditions. This segment’s growth is driven by the increasing number of interventional procedures and the need for effective valve treatments.
The global Large Bore Vascular Closure Devices market is characterized by diverse product types and applications, each with distinct growth dynamics. The 10F-15F product type holds the largest market share, while the 16F-18F segment is the fastest-growing. Regarding applications, TAVR dominates the market, and EVAR closely follows. The growth of these segments is driven by increasing medical needs, technological advancements, and expanding clinical indications. As the market continues to evolve, ongoing innovations and regulatory support will be crucial in addressing the challenges and maximizing the potential of Large Bore Vascular Closure Devices.
Market Revenue and Share by Segment
| Market Revenue (M USD) in 2025 | Market Share in 2025 | ||
| By Type | 10F-15F | 415.63 | 50.05% |
| 16F-18F | 267.09 | 32.17% | |
| 19-25F | 115.62 | 13.92% | |
| By Application | TAVR | 328.91 | 39.61% |
| EVAR | 250.75 | 30.20% | |
| VAD | 88.68 | 10.68% | |
| BAV | 112.39 | 13.54% |
5. Regional Large Bore Vascular Closure Devices Market
Among these regions, North America emerges as the largest market with revenue of $287.98 million in 2025. The dominance of North America can be attributed to several factors, including a well-established healthcare infrastructure, high demand for advanced medical devices, and significant investments in research and development. The United States, in particular, is a major contributor to this region’s market revenue, driven by a high prevalence of cardiovascular diseases and a robust healthcare system that supports the adoption of advanced medical technologies.
The Asia-Pacific region is the fastest-growing, with a revenue of $257.40 in 2025. This rapid growth is fueled by the region’s expanding healthcare market, increasing awareness of cardiovascular diseases, and growing demand for minimally invasive procedures. Countries like China and Japan are key drivers, with significant investments in healthcare infrastructure and a growing aging population that requires advanced medical interventions.
Europe, while not the fastest-growing region, remains a significant market with a market size of $241.66 million in 2025. The region benefits from a strong healthcare system and a high demand for advanced medical devices. Germany, the UK, and France are major contributors to Europe’s market revenue, driven by their advanced healthcare systems and significant investments in medical technology.
Global Large Bore Vascular Closure Devices Revenue (M USD) by Regions in 2025
6. Top 3 Companies in the Large Bore Vascular Closure Devices Market
Abbott Laboratories (St. Jude Medical)
Company Introduction and Business Overview:
Abbott Laboratories, through its subsidiary St. Jude Medical, is a global leader in the development, manufacture, and sale of healthcare products. The company has a strong presence in the cardiovascular device market, offering a wide range of products designed to improve patient outcomes and enhance procedural efficiency.
Products Offered:
Abbott’s portfolio includes the Perclose ProGlide™ Suture-Mediated Closure System, which is widely recognized for its effectiveness in large bore vascular closure procedures. This system is designed to provide secure closure with reduced time to hemostasis, ambulation, and discharge compared to manual compression.
Company Introduction and Business Overview:
Cardinal Health is a leading integrated healthcare services and products company with a global presence. The company operates across various segments, including pharmaceutical distribution, medical products, and specialty solutions. Cardinal Health is known for its commitment to improving healthcare outcomes through innovative products and services.
Products Offered:
Cardinal Health offers the MYNXGRIP® device, which provides secure mechanical closure with an extravascular sealant. This device is designed to offer patient-friendly closure options, eliminating the need for sutures, metal implants, and reducing the risk of complications.
Company Introduction and Business Overview:
Teleflex is a global provider of medical devices with a strong focus on vascular access, urology, cardiac care, and surgery. The company’s Vascular Solutions division is dedicated to developing and manufacturing advanced medical devices that improve patient care and procedural outcomes.
Products Offered:
Teleflex’s MANTA® Vascular Closure Device is a key product in the large bore vascular closure market. This device is designed to effectively close femoral arterial access sites following large bore procedures, offering rapid hemostasis and reduced procedural time.
Major Players
| Company Name | Plants Distribution | Sales Region |
| Abbott Laboratories (St. Jude Medical) | USA, Europe, China, etc. | Worldwide |
| Cardinal Health | USA, Europe, Japan, etc. | Worldwide |
| Teleflex (Vascular Solutions) | USA | Worldwide |
| Vivasure Medical | Europe | Mainly in Europe |
| InSeal Medical | Israel | Europe, India, the Middle East and Africa, etc. |